Trademark: 90207345
Word
XFREE
Status
Registered
Status Code
700
Status Date
Tuesday, January 11, 2022
Serial Number
90207345
Registration Number
6616598
Registration Date
Tuesday, January 11, 2022
Mark Type
4000
Filing Date
Thursday, September 24, 2020
Published for Opposition
Tuesday, April 27, 2021

Trademark Owner History
BioGX, Inc. - Original Registrant

Classifications
1 Reagents, namely, reagents for medical research testing or for scientific research use; molecular reagents, namely, lyophilized reagents for chemical testing purposes in scientific research; molecular reagents, namely, custom lyophilized reagents for chemical testing for scientific or medical research purposes; molecular reagents, namely, lyophilized reagents for chemical testing purposes, namely, for clinical laboratory use, food safety testing, pharmaceutical testing and water quality analysis for scientific research purposes; molecular reagents, namely, molecular diagnostic reagents for scientific or research use in connection with genetic materials; molecular reagents, namely, molecular reagents for use in real-time PCR and nucleic sequencing platforms for scientific or medical research use
5 Medical diagnostic tests for infectious and genetic diseases; medical diagnostic tests including reagents to test for infectious and genetic diseases; medical diagnostic tests employing polymerase chain reaction (PCR) to test for infectious and genetic diseases; reagents, namely, reagents for medical diagnostic testing use; molecular reagents, namely, lyophilized reagents for chemical testing purposes for medical or veterinary use; molecular reagents, namely, custom lyophilized reagents for chemical testing purposes for medical or veterinary use; molecular reagents, namely, lyophilized reagents for chemical testing purposes, namely, clinical medical reagents and chemical reagents for medicinal pharmaceutical use; molecular reagents, namely, molecular reagents for medical diagnostic use in connection with genetic materials; molecular reagents, namely, molecular reagents for medical diagnostic use in real-time PCR and nucleic sequencing platforms
X FREE

Trademark Events
Jan 11, 2022
Registered-Principal Register
Dec 7, 2021
Notice Of Acceptance Of Statement Of Use E-Mailed
Dec 6, 2021
Allowed Principal Register - Sou Accepted
Dec 4, 2021
Statement Of Use Processing Complete
Nov 6, 2021
Use Amendment Filed
Dec 4, 2021
Case Assigned To Intent To Use Paralegal
Nov 6, 2021
Teas Statement Of Use Received
Jun 22, 2021
Noa E-Mailed - Sou Required From Applicant
Apr 27, 2021
Official Gazette Publication Confirmation E-Mailed
Apr 27, 2021
Published For Opposition
Apr 7, 2021
Notification Of Notice Of Publication E-Mailed
Mar 22, 2021
Approved For Pub - Principal Register
Mar 20, 2021
Teas/Email Correspondence Entered
Mar 19, 2021
Correspondence Received In Law Office
Mar 19, 2021
Teas Response To Office Action Received
Feb 18, 2021
Notification Of Non-Final Action E-Mailed
Feb 18, 2021
Non-Final Action E-Mailed
Feb 18, 2021
Non-Final Action Written
Feb 12, 2021
Assigned To Examiner
Nov 3, 2020
New Application Office Supplied Data Entered In Tram
Sep 28, 2020
New Application Entered In Tram

PI
WC
Trademark Alertz updated from USPTO on 2030-01-24